Clinical Trials Browser

Terminated × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Arsenic Trioxide × Clear all

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00006092 2012-09-26

Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)

Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia